Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	40.4	11.81	33.51	25.18
Short-Term Investments	19.65	14.86	-	-
Cash & Short-Term Investments	60.05	26.67	33.51	25.18
Cash Growth	139.31%	-20.41%	33.10%	-
Accounts Receivable	25.88	19.59	15.16	15.61
Other Receivables	0.23	5.19	1.29	-
Receivables	26.8	29.15	16.84	17.14
Inventory	8.85	6.34	4.28	6.12
Prepaid Expenses	2.87	1.19	1.55	0.38
Other Current Assets	-	1.44	1.05	0.84
Total Current Assets	98.58	64.79	57.22	49.65
Property, Plant & Equipment	24.91	25.7	23.78	18.38
Long-Term Investments	20.32	24.57	23.43	7.39
Other Intangible Assets	4.85	1.71	1.7	1.86
Long-Term Deferred Tax Assets	6.71	5.62	4.7	4.08
Other Long-Term Assets	4.02	3.03	5.72	3.39
Total Assets	159.38	125.41	116.54	84.75
Accounts Payable	0.56	0.11	0.36	0.12
Accrued Expenses	9.46	9.3	10.56	6.77
Current Portion of Leases	0.63	0.71	0.21	0.49
Current Income Taxes Payable	2.65	2.83	5.05	2.1
Current Unearned Revenue	0.15	0.16	0.08	0.17
Other Current Liabilities	2.47	6.41	3.79	2.59
Total Current Liabilities	15.91	19.52	20.05	12.24
Long-Term Leases	0.54	0.89	0.2	0.12
Long-Term Unearned Revenue	0.87	0.93	0.21	0.12
Other Long-Term Liabilities	4.65	5.68	17.61	0.06
Total Liabilities	21.97	27	38.07	12.54
Common Stock	0.09	0.09	0.08	0.06
Additional Paid-In Capital	167.13	136.19	68.18	32.8
Retained Earnings	-63.61	-70.36	-82.44	10.06
Comprehensive Income & Other	-1.7	-2.6	-1.64	-0.39
Total Common Equity	101.92	63.32	-15.83	42.52
Minority Interest	35.5	35.08	29.78	29.7
Shareholders' Equity	137.42	98.4	78.47	72.22
Total Liabilities & Equity	159.38	125.41	116.54	84.75
Total Debt	1.17	1.6	0.41	0.61
Net Cash (Debt)	58.88	25.07	33.1	24.56
Net Cash Growth	152.75%	-24.25%	34.76%	-
Net Cash Per Share	0.57	0.25	0.50	0.32
Filing Date Shares Outstanding	90.89	93.61	85.42	63.59
Total Common Shares Outstanding	90.89	86.31	76.6	63.59
Working Capital	82.66	45.27	37.17	37.41
Book Value Per Share	1.12	0.73	-0.21	0.67
Tangible Book Value	97.07	61.61	-17.53	40.67
Tangible Book Value Per Share	1.07	0.71	-0.23	0.64
Buildings	19.23	18.98	12.29	10.84
Machinery	10.47	10.28	7.39	5.69
Construction In Progress	0.84	0.22	7.88	4.85
Leasehold Improvements	-	-	-	0.33

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q